SG11201700557RA - Lipid membrane structure, lipid-membrane-structure-immobilization carrier, and method for fusing cells - Google Patents

Lipid membrane structure, lipid-membrane-structure-immobilization carrier, and method for fusing cells

Info

Publication number
SG11201700557RA
SG11201700557RA SG11201700557RA SG11201700557RA SG11201700557RA SG 11201700557R A SG11201700557R A SG 11201700557RA SG 11201700557R A SG11201700557R A SG 11201700557RA SG 11201700557R A SG11201700557R A SG 11201700557RA SG 11201700557R A SG11201700557R A SG 11201700557RA
Authority
SG
Singapore
Prior art keywords
lipid
membrane
immobilization carrier
fusing cells
fusing
Prior art date
Application number
SG11201700557RA
Other languages
English (en)
Inventor
Takumi Hirase
Rii MORIMURA
Masato Nakayama
Original Assignee
Toppan Printing Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toppan Printing Co Ltd filed Critical Toppan Printing Co Ltd
Publication of SG11201700557RA publication Critical patent/SG11201700557RA/en

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02Making microcapsules or microballoons
    • B01J13/20After-treatment of capsule walls, e.g. hardening
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6428Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1088Heterocyclic compounds characterised by ligands containing oxygen as the only heteroatom
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6428Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • G01N2021/6439Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • G01N21/77Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
    • G01N21/78Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a change of colour

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Materials Engineering (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Optics & Photonics (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Colloid Chemistry (AREA)
SG11201700557RA 2014-07-24 2015-07-24 Lipid membrane structure, lipid-membrane-structure-immobilization carrier, and method for fusing cells SG11201700557RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2014150868 2014-07-24
PCT/JP2015/071118 WO2016013660A1 (ja) 2014-07-24 2015-07-24 脂質膜構造体、脂質膜構造体固定化担体、及び胞体の融合方法

Publications (1)

Publication Number Publication Date
SG11201700557RA true SG11201700557RA (en) 2017-02-27

Family

ID=55163182

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201700557RA SG11201700557RA (en) 2014-07-24 2015-07-24 Lipid membrane structure, lipid-membrane-structure-immobilization carrier, and method for fusing cells

Country Status (6)

Country Link
US (2) US10807061B2 (de)
EP (1) EP3173143A4 (de)
JP (1) JP6597614B2 (de)
CN (1) CN106573220B (de)
SG (1) SG11201700557RA (de)
WO (1) WO2016013660A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017141947A1 (ja) * 2016-02-15 2017-08-24 凸版印刷株式会社 エクソソーム複合体の形成方法
KR101962172B1 (ko) * 2017-09-20 2019-07-18 서강대학교산학협력단 자성 광합성 세포막 소낭을 이용한 트랜스-레스베라트롤의 생산 방법
CN108546671A (zh) * 2018-04-17 2018-09-18 马英淙 一种生物样品中细胞微囊泡的分离方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3442133B2 (ja) * 1994-03-03 2003-09-02 Tdk株式会社 磁性細菌マグネトソーム及び遺伝子を含有するリポソーム並びにそれを利用する細胞への遺伝子の導入方法
US5591448A (en) * 1994-11-21 1997-01-07 Tepic; Slobodan Anti-viral therapeutic composition
FR2788780B1 (fr) 1999-01-27 2001-03-30 Ap Cells Inc Procede de preparation de vesicules membranaires
US20040241176A1 (en) 2000-04-27 2004-12-02 Ap Cells. Inc. Method of producing membrane vesicles
WO2004025300A1 (ja) * 2002-09-13 2004-03-25 Hitachi Chemical Co., Ltd. 固定化用担体および固相
EP1650293B1 (de) * 2003-06-30 2010-12-15 Eisai R&D Management Co., Ltd. Magnetische zelle und verfahren zur verwendung davon
EP1548444A1 (de) * 2003-12-23 2005-06-29 Paul Scherrer Institut Vorrichtung (Assay Chip) und Verfahren zur Bestimmung von Molekularen Strukturen und Funktionen
JP2006034211A (ja) * 2004-07-29 2006-02-09 Nagoya Institute Of Technology 酸性条件で膜融合を促進するペプチド誘導体
JP2008029952A (ja) * 2006-07-28 2008-02-14 National Institute Of Advanced Industrial & Technology ベシクルを利用した並列反応方法
JP2008081486A (ja) * 2006-08-31 2008-04-10 Canon Inc 細胞融合性リポソーム及び該リポソームを利用した物質導入方法
US20100055724A1 (en) 2007-01-26 2010-03-04 University Of Louisville Research Foundation, Inc. Methods of detecting autoantibodies for diagnosing and characterizing disorders
CN103276062A (zh) 2007-07-25 2013-09-04 路易斯维尔大学研究基金会公司 作为诊断标记物的外来体相关微rna
JP2011524164A (ja) 2008-06-06 2011-09-01 サントル・ナシオナル・ドウ・ラ・ルシエルシユ・シアンテイフイク(セー・エヌ・エール・エス) 小分子rnaに基づく治療および診断ならびに小分子rnaの実験的研究におけるエンドリソソーム系および分泌小胞(エキソソーム様)の用途
JP2012508233A (ja) * 2008-11-07 2012-04-05 チルドレンズ ホスピタル メディカル センター 膜貫通薬物送達システムへの適用のためのサポシンc、並びに関連のタンパク質及びペプチドの融合性
WO2010085259A1 (en) * 2009-01-26 2010-07-29 Nanotrope, Inc. Viral detection liposomes and method
ES2749393T3 (es) * 2009-04-17 2020-03-20 Univ Oxford Innovation Ltd Composición para entrega de material genético
JP5732474B2 (ja) 2010-01-08 2015-06-10 カヴァディス・ベスローテン・フェンノートシャップ 心血管系イベントを予測するためのエキソソームバイオマーカーの決定
JP2013007698A (ja) 2011-06-27 2013-01-10 Univ Of Miyazaki 腎における小胞体ストレス応答の検出方法
DE102013009744A1 (de) * 2013-03-26 2014-10-02 Forschungszentrum Jülich GmbH Fusionsmischung zur lipidhaltigen Membranmodifikation einer beliebigen Lipidmembran, einer Zellmembran, einem Bestandteil einer Zellmembran oder einer von den übrigen Zell- Bestandteilen getrennten Zellmembran in vivo oder in vitro

Also Published As

Publication number Publication date
CN106573220B (zh) 2019-08-16
US10807061B2 (en) 2020-10-20
US20200406219A1 (en) 2020-12-31
JPWO2016013660A1 (ja) 2017-06-15
CN106573220A (zh) 2017-04-19
WO2016013660A1 (ja) 2016-01-28
EP3173143A1 (de) 2017-05-31
JP6597614B2 (ja) 2019-10-30
US20170128904A1 (en) 2017-05-11
EP3173143A4 (de) 2018-06-27

Similar Documents

Publication Publication Date Title
SG11201706826VA (en) Method for separating cells, and device therefor
EP3217064A4 (de) Wasserstofftankstelle
HUE039422T2 (hu) Kiszerelés, összeállítás és eljárás italok készítésére
EP3203530A4 (de) Solarzelle und verfahren zur herstellung davon
EP3124432A4 (de) Wasserstofferzeugungssystem und verfahren zur wasserstofferzeugung
EP3236559A4 (de) Elektrisches speichersystem und elektrisches speicherverfahren
IL247445A0 (en) System and method for gliding cells and monitoring
EP3128098A4 (de) Solarzellenvorrichtung
EP3176905A4 (de) Stromspeichersystem und stromspeicherverfahren
EP3133865A4 (de) Verfahren, vorrichtung und system zur zellenneuauswahl
EP3091786A4 (de) Vorrichtung, verfahren und system zur zellenauswahl
EP3168917A4 (de) Flüssigelektrolyt und verfahren zur herstellung von phosphat
EP3091067A4 (de) Zellenträger und vorrichtung, verfahren und system zur herstellung einer zellstruktur
EP3157062A4 (de) Solarzelle und verfahren zur herstellung einer solarzelle
EP3206433A4 (de) Verfahren, vorrichtung und system zum umschalten zwischen kleinen zellen
IL266111A (en) Methods for inducing a t-cell response
EP3187578A4 (de) Zelleinfangverfahren, verfahren zur herstellung einer vorrichtung zum einfangen spezifischer zellen und verfahren zur herstellung einer lösung mit spezifischen zellen
EP3220464A4 (de) Zellstruktur, verfahren zur herstellung davon und brennstoffzelle
IL248598A0 (en) Foods, systems, methods and kits for providing electrolyte replacements
EP3237897A4 (de) Elektrochemisches testsystem
EP3099122A4 (de) Verfahren, zelle und system zur implementierung einer luftschnittstellensynchronisation
EP3208329A4 (de) Verfahren zur herstellung von gamma-delta-t-zellen und arzneimittel
EP3358003A4 (de) Verfahren zur herstellung einer blattförmigen zellstruktur und blattförmige zellstruktur
EP3156080A4 (de) Zellstruktur und verfahren zur herstellung der zellstruktur
EP3111945A4 (de) Arzneimittel mit dendritischen zellen und verfahren zur herstellung davon